MariMed Inc. (MRMD)
(Delayed Data from OTC)
$0.18 USD
+0.02 (11.11%)
Updated Sep 9, 2024 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for MariMed Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 149 | 134 | 121 | 51 | 46 |
Cost Of Goods | 83 | 70 | 55 | 20 | 27 |
Gross Profit | 66 | 64 | 66 | 31 | 19 |
Selling & Adminstrative & Depr. & Amort Expenses | 52 | 44 | 39 | 17 | 60 |
Income After Depreciation & Amortization | 14 | 20 | 27 | 15 | -42 |
Non-Operating Income | -12 | 1 | -1 | 0 | -28 |
Interest Expense | 9 | 2 | 2 | 10 | 13 |
Pretax Income | -7 | 20 | 24 | 5 | -82 |
Income Taxes | 9 | 6 | 16 | 2 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | -1 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -16 | 14 | 8 | 2 | -82 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -16 | 13 | 7 | 2 | -81 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 26 | 25 | 45 | 22 | -28 |
Depreciation & Amortization (Cash Flow) | 12 | 5 | 18 | 8 | 14 |
Income After Depreciation & Amortization | 14 | 20 | 27 | 15 | -42 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 363.40 | 380.29 | 372.40 | NA | 208.72 |
Diluted EPS Before Non-Recurring Items | 0.00 | 0.05 | 0.02 | NA | -0.25 |
Diluted Net EPS (GAAP) | -0.04 | 0.04 | 0.02 | 0.01 | -0.39 |
Fiscal Year end for MariMed Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 40.44 | 37.93 | 38.90 | 38.80 | 36.52 |
Cost Of Goods | 23.53 | 21.46 | 21.58 | 21.96 | 20.14 |
Gross Profit | 16.91 | 16.47 | 17.32 | 16.84 | 16.38 |
SG&A, R&D, and Dept/Amort Expenses | 15.95 | 14.45 | 14.91 | 13.55 | 12.83 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.96 | 2.02 | 2.41 | 3.29 | 3.55 |
Non-Operating Income | 0.00 | 0.01 | -10.48 | -0.62 | 0.11 |
Interest Expense | 1.72 | 1.63 | 1.56 | 2.48 | 2.64 |
Pretax Income | -0.77 | 0.40 | -9.63 | 0.19 | 1.01 |
Income Taxes | 0.87 | 1.69 | 0.51 | 4.46 | 1.95 |
Minority Interest | 0.01 | 0.01 | 0.03 | -0.01 | 0.02 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.64 | -1.29 | -10.14 | -4.27 | -0.94 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.65 | -1.30 | -10.17 | -4.26 | -0.96 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 379.51 | 375.21 | 376.01 | 373.08 | 361.26 |
Diluted EPS Before Non-Recurring Items | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
Diluted Net EPS (GAAP) | 0.00 | 0.00 | -0.03 | -0.01 | 0.00 |